EXELA PHARMA SCIENCES

NC

Pharmaceutical Manufacturer

Active 2017–2026. The register lists this client once for every firm that files on its behalf; all 3 of its records are shown together here.

Filings
58
Filed By
3
Reported In-House
—
Reported By Firms
$2,287,000

Filings

YearFirmPeriodAmountDoc
2026 OLD NORTH STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$27,000
2026 OLD NORTH STRATEGIES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$27,000
2026 OLD NORTH STRATEGIES, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$27,000
2025 OLD NORTH STRATEGIES, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$138,000
2025 OLD NORTH STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$138,000
2025 OLD NORTH STRATEGIES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$138,000
2025 OLD NORTH STRATEGIES, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$138,000
2024 OLD NORTH STRATEGIES, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$108,000
2024 BROYDRICK & ASSOCIATES 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Termination (No Activity)
—
2024 OLD NORTH STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$108,000
Page 1 of 6  ·  58 filings Next
Filed By
FirmFilingsAmount
OLD NORTH STRATEGIES, LLC 21 $1,707,000
FIDELIS GOVERNMENT RELATIONS 8 $390,000
BROYDRICK & ASSOCIATES 29 $190,000
Issue Areas